Literature DB >> 34452307

Serological Evidence of Widespread Zika Transmission across the Philippines.

Joseph R Biggs1, Ava Kristy Sy2,3, Oliver J Brady4,5, Adam J Kucharski4,5, Sebastian Funk4,5, Yun-Hung Tu6, Mary Anne Joy Reyes2,3, Mary Ann Quinones2,3, William Jones-Warner1, James Ashall1, Ferchito L Avelino7, Nemia L Sucaldito7, Amado O Tandoc2, Eva Cutiongco-de la Paz8,9, Maria Rosario Z Capeding3,8, Carmencita D Padilla8,9, Martin L Hibberd1,8,9, Julius Clemence R Hafalla1.   

Abstract

Zika virus (ZIKV) exposure across flavivirus-endemic countries, including the Philippines, remains largely unknown despite sporadic case reporting and environmental suitability for transmission. Using laboratory surveillance data from 2016, 997 serum samples were randomly selected from suspected dengue (DENV) case reports across the Philippines and assayed for serological markers of short-term (IgM) and long-term (IgG) ZIKV exposure. Using mixture models, we re-evaluated ZIKV IgM/G seroprevalence thresholds and used catalytic models to quantify the force of infection (attack rate, AR) from age-accumulated ZIKV exposure. While we observed extensive ZIKV/DENV IgG cross-reactivity, not all individuals with active DENV presented with elevated ZIKV IgG, and a proportion of dengue-negative cases (DENV IgG-) were ZIKV IgG-positive (14.3%, 9/63). We identified evidence of long-term, yet not short-term, ZIKV exposure across Philippine regions (ZIKV IgG+: 31.5%, 314/997) which was geographically uncorrelated with DENV exposure. In contrast to the DENV AR (12.7% (95%CI: 9.1-17.4%)), the ZIKV AR was lower (5.7% (95%CI: 3-11%)) across the country. Our results provide evidence of widespread ZIKV exposure across the Philippines and suggest the need for studies to identify ZIKV infection risk factors over time to better prepare for potential future outbreaks.

Entities:  

Keywords:  Philippines; Zika; dengue; diagnostics; force of infection; serology

Mesh:

Substances:

Year:  2021        PMID: 34452307      PMCID: PMC8402696          DOI: 10.3390/v13081441

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  34 in total

1.  Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays.

Authors:  Christophe Pasquier; Guillaume Joguet; Catherine Mengelle; Sabine Chapuy-Regaud; Lynda Pavili; Nadia Prisant; Jacques Izopet; Louis Bujan; Jean-Michel Mansuy
Journal:  Diagn Microbiol Infect Dis       Date:  2017-09-15       Impact factor: 2.803

2.  Long-term circulation of Zika virus in Thailand: an observational study.

Authors:  Kriangsak Ruchusatsawat; Pattara Wongjaroen; Arisara Posanacharoen; Isabel Rodriguez-Barraquer; Somchai Sangkitporn; Derek A T Cummings; Henrik Salje
Journal:  Lancet Infect Dis       Date:  2019-02-27       Impact factor: 25.071

3.  High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses.

Authors:  Daniela Huzly; Ingeborg Hanselmann; Jonas Schmidt-Chanasit; Marcus Panning
Journal:  Euro Surveill       Date:  2016-04-21

4.  Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study.

Authors:  Mars Stone; Sonia Bakkour; Marion C Lanteri; Donald Brambilla; Graham Simmons; Roberta Bruhn; Zhanna Kaidarova; Tzong-Hae Lee; Jose Orlando Alsina; Phillip C Williamson; Susan A Galel; Lisa L Pate; Jeffrey M Linnen; Steve Kleinman; Michael P Busch
Journal:  Lancet Infect Dis       Date:  2020-07-13       Impact factor: 25.071

5.  Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques.

Authors:  Jeffy George; William G Valiant; Mary J Mattapallil; Michelle Walker; Yan-Jang S Huang; Dana L Vanlandingham; John Misamore; Jack Greenhouse; Deborah E Weiss; Daniela Verthelyi; Stephen Higgs; Hanne Andersen; Mark G Lewis; Joseph J Mattapallil
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

6.  Correlation of clinical illness with viremia in Zika virus disease during an outbreak in Singapore.

Authors:  Deborah H L Ng; Hanley J Ho; Angela Chow; Joshua Wong; Win Mar Kyaw; Adriana Tan; Po Ying Chia; Chiaw Yee Choy; Glorijoy Tan; Tsin Wen Yeo; Yee Sin Leo
Journal:  BMC Infect Dis       Date:  2018-07-04       Impact factor: 3.090

7.  The association between Zika virus infection and microcephaly in Brazil 2015-2017: An observational analysis of over 4 million births.

Authors:  Oliver J Brady; Aaron Osgood-Zimmerman; Nicholas J Kassebaum; Sarah E Ray; Valdelaine E M de Araújo; Aglaêr A da Nóbrega; Livia C V Frutuoso; Roberto C R Lecca; Antony Stevens; Bruno Zoca de Oliveira; José M de Lima; Isaac I Bogoch; Philippe Mayaud; Thomas Jaenisch; Ali H Mokdad; Christopher J L Murray; Simon I Hay; Robert C Reiner; Fatima Marinho
Journal:  PLoS Med       Date:  2019-03-05       Impact factor: 11.069

8.  Evaluation of ViroTrack Sero Zika IgG/IgM, a New Rapid and Quantitative Zika Serological Diagnostic Assay.

Authors:  Tony Liao; Xiaole Wang; Marco Donolato; Eva Harris; Magelda Montoya Cruz; Angel Balmaseda; Robert Y L Wang
Journal:  Diagnostics (Basel)       Date:  2020-06-04

9.  Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection.

Authors:  Mariana Kikuti; Laura B Tauro; Patrícia S S Moreira; Gúbio S Campos; Igor A D Paploski; Scott C Weaver; Mitermayer G Reis; Uriel Kitron; Guilherme S Ribeiro
Journal:  Virol J       Date:  2018-07-13       Impact factor: 4.099

10.  Zika Virus Infection, Philippines, 2012.

Authors:  Corazon Cerilla Buerano; Lady-Anne Suarez Pangilinan; Maria Terrese Alonzo Dimamay; Cynthia Abad Mapua; Mark Pierre Sijo Dimamay; Ronald Roll Matias; Filipinas Florendo Natividad; Maria Luisa de Guzman Daroy; Futoshi Hasebe; Kouichi Morita; Meng Ling Moi
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

View more
  1 in total

1.  Combining rapid diagnostic tests to estimate primary and post-primary dengue immune status at the point of care.

Authors:  Joseph R Biggs; Ava Kristy Sy; James Ashall; Marsha S Santoso; Oliver J Brady; Mary Anne Joy Reyes; Mary Ann Quinones; William Jones-Warner; Amadou O Tandoc; Nemia L Sucaldito; Huynh Kim Mai; Le Thuy Lien; Hung Do Thai; Hien Anh Thi Nguyen; Dang Duc Anh; Chihiro Iwasaki; Noriko Kitamura; Marnix Van Loock; Guillermo Herrera-Taracena; Joris Menten; Freya Rasschaert; Liesbeth Van Wesenbeeck; Sri Masyeni; Sotianingsih Haryanto; Benediktus Yohan; Eva Cutiongco-de la Paz; Lay-Myint Yoshida; Stephane Hue; Maria Rosario Z Capeding; Carmencita D Padilla; R Tedjo Sasmono; Julius Clemence R Hafalla; Martin L Hibberd
Journal:  PLoS Negl Trop Dis       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.